Structure-activity relationships of a series of novel (piperazinylbutyl)thiazolidinone antipsychotic agents related to 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5- trimethyl-4-thiazolidinone maleate.

Article Details

Citation

Hrib NJ, Jurcak JG, Bregna DE, Burgher KL, Hartman HB, Kafka S, Kerman LL, Kongsamut S, Roehr JE, Szewczak MR, Woods-Kettelberger AT, Corbett R

Structure-activity relationships of a series of novel (piperazinylbutyl)thiazolidinone antipsychotic agents related to 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5- trimethyl-4-thiazolidinone maleate.

J Med Chem. 1996 Sep 27;39(20):4044-57.

PubMed ID
8831770 [ View in PubMed
]
Abstract

HP-236 (3-[4-[4-(6-Fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5- trimethyl-4-thiazolidinone maleate; P-9236) (54) displayed a pharmacological profile indicative of potential atypical antipsychotic activity. A series of piperazinyl butyl thiazolidinones structurally related to this compound were prepared and evaluated in vitro for dopamine D2 and serotonin 5HT2 and 5HT1A receptor affinity. The compounds were examined in vivo in animal models of potential antipsychotic activity and screened in models predictive of extrapyramidal side effect (EPS) liability. The synthesis of these compounds, details of their structure-activity relationships, and discovery of a new lead, compound 50, as well as further development of the profiles of compounds 50 and 54 are described.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
Clozapine5-hydroxytryptamine receptor 2AIC 50 (nM)12N/AN/ADetails
Clozapine5-hydroxytryptamine receptor 2AKi (nM)5N/AN/ADetails
ClozapineDopamine D4 receptorKi (nM)10N/AN/ADetails
ClozapineDopamine D4 receptorIC 50 (nM)58N/AN/ADetails
Haloperidol5-hydroxytryptamine receptor 2AIC 50 (nM)288N/AN/ADetails
Haloperidol5-hydroxytryptamine receptor 2AKi (nM)108N/AN/ADetails
Olanzapine5-hydroxytryptamine receptor 2AIC 50 (nM)9N/AN/ADetails
Olanzapine5-hydroxytryptamine receptor 2AKi (nM)4N/AN/ADetails
OlanzapineDopamine D4 receptorIC 50 (nM)173N/AN/ADetails
OlanzapineDopamine D4 receptorKi (nM)29N/AN/ADetails